Yugo Yamashita

Apr 8, 2024 | uscjournal.com | David Austin |Harriette Van Spall |James L. Januzzi |Yugo Yamashita

ACC.24 — We are joined onsite by Dr David Austin (South Tees Hospitals NHS Foundation Trust, UK) to discuss the findings from the PROACT trial (NCT03265574). Anthracyclines used in the treatment of breast cancer cause damage to the muscle cells in the heart, resulting in cardiotoxicityPROACT is a phase III randomised superiority trial of enalapril for the prevention of anthracycline-induced cardiotoxicity in patients treated for breast cancer and lymphoma.

Nov 9, 2023 | uscjournal.com | Joost Daemen |Craig Smith |Ankur Kalra |Yugo Yamashita

What should you keep an eye out for at this year's AHA Scientific Sessions? Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, NL) return with their 'View from the Thoraxcenter' preview to highlight late-breaking and featured science trials being presented at this year's AHA Scientific Sessions. Join this dynamic discussion on some of the most anticipated data releases.

May 25, 2023 | pubmed.ncbi.nlm.nih.gov | Yugo Yamashita

Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software